Phase III study of Remdesivir in Moderate COVID-19 patients
Clinical Trial Grant
Administered By
Medicine, Infectious Diseases
Awarded By
Gilead Sciences, Inc.
Start Date
March 31, 2020
End Date
March 30, 2021
Administered By
Medicine, Infectious Diseases
Awarded By
Gilead Sciences, Inc.
Start Date
March 31, 2020
End Date
March 30, 2021